1. Home
  2. CBNK vs ANAB Comparison

CBNK vs ANAB Comparison

Compare CBNK & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBNK
  • ANAB
  • Stock Information
  • Founded
  • CBNK 1974
  • ANAB 2005
  • Country
  • CBNK United States
  • ANAB United States
  • Employees
  • CBNK N/A
  • ANAB N/A
  • Industry
  • CBNK Major Banks
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBNK Finance
  • ANAB Health Care
  • Exchange
  • CBNK Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • CBNK 517.6M
  • ANAB 621.1M
  • IPO Year
  • CBNK 2018
  • ANAB 2017
  • Fundamental
  • Price
  • CBNK $33.64
  • ANAB $22.47
  • Analyst Decision
  • CBNK Hold
  • ANAB Buy
  • Analyst Count
  • CBNK 1
  • ANAB 10
  • Target Price
  • CBNK $35.00
  • ANAB $44.25
  • AVG Volume (30 Days)
  • CBNK 78.0K
  • ANAB 661.9K
  • Earning Date
  • CBNK 07-21-2025
  • ANAB 08-04-2025
  • Dividend Yield
  • CBNK 1.19%
  • ANAB N/A
  • EPS Growth
  • CBNK 6.54
  • ANAB N/A
  • EPS
  • CBNK 2.49
  • ANAB N/A
  • Revenue
  • CBNK $188,910,000.00
  • ANAB $111,872,000.00
  • Revenue This Year
  • CBNK $46.92
  • ANAB N/A
  • Revenue Next Year
  • CBNK $7.82
  • ANAB $24.39
  • P/E Ratio
  • CBNK $13.47
  • ANAB N/A
  • Revenue Growth
  • CBNK 20.92
  • ANAB 387.20
  • 52 Week Low
  • CBNK $19.70
  • ANAB $12.21
  • 52 Week High
  • CBNK $34.31
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • CBNK 64.12
  • ANAB 49.83
  • Support Level
  • CBNK $31.99
  • ANAB $22.49
  • Resistance Level
  • CBNK $32.98
  • ANAB $24.86
  • Average True Range (ATR)
  • CBNK 0.62
  • ANAB 1.27
  • MACD
  • CBNK 0.14
  • ANAB -0.17
  • Stochastic Oscillator
  • CBNK 100.00
  • ANAB 10.49

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: